Serviços Personalizados
Journal
Artigo
Indicadores
Citado por SciELO
Acessos
Links relacionados
Similares em SciELO
Compartilhar
Acta médica Grupo Ángeles
versão impressa ISSN 1870-7203
Resumo
MARTINEZ ALVAREZ, Tania Gabriela et al. Decreased opioid consumption with the use of dexmedetomidine during the transanesthetic period. Acta méd. Grupo Ángeles [online]. 2021, vol.19, n.4, pp.491-496. Epub 01-Ago-2022. ISSN 1870-7203. https://doi.org/10.35366/102533.
Introduction:
Recently the objectives of major surgery have been a focus on offering the best possibilities that lead to a fast recovery and the return of the patient to his daily task, and this must be carried with adequate analgesic quality, this matter represents a challenge for the anesthesiologist choosing which drug to use during the trans-anesthetic period.
Material and methods:
This is a study of case and control type, 26 patients were studied any type of major noncardiac surgery under balanced general anesthesia, with the aim of quantifying the consumption of intraoperative fentanyl, In a homogeneous population, it was determined that there is lower consumption of trans anesthetic opioids in the group that was perfused with dexmedetomidine with a value of p < 0.05, as well as a better analgesic quality, this last one was measured using the numerical scale of pain.
Results:
Thus, concluding that the use of dexmedetomidine as an infusion during the trans anesthetic period reduces the consumption of opioids and probably contributes to a faster recovery.
Palavras-chave : Multimodal analgesia; imidazole receptor; agonist α-2; general anesthesia; decrease in opioid consumption.